One Stop Shop for All Your Market Research Reports

Global G-Protein Coupled Receptor (GPCR) Targeting Market by Manufacturers, Regions, Type and Application, Forecast to 2023

G protein?coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein?linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times. Scope of the Report: This report focuses on the G-Protein Coupled Receptor (GPCR) Targeting in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. In the next five years, the GACR of GPCR Tools is about 3.6%, and the revenue in the 2022 is about 1760 M USD. GPCRs market comprises assays and kits that aid in drug discovery and development. GPCRs is a large family of cell surface receptors that respond to a diverse range of external stimulus and play a major role in modern pharmacology due to their significant function in cell communication. More than 40% of the drugs available in the global market target GPCRs and most of the drugs that are currently under clinical and preclinical studies target this highly studied receptor protein. The classification of GPCR Tools includes GPCR Consumables and GPCR Equipment, and the proportion of GPCR Consumables in 2016 is about 70% and the proportion is increasing trend from 2012 to 2016. In terms of therapeutic areas, the market has been segmented into: Oncology, cardiovascular system, central nervous system (CNS), etc. Oncology was the largest segment of the global GPCRs market in 2016 and the proportion in 2016 is 50%. North America is the largest consumption place, with a consumption market share nearly 49% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30.4%. Market competition is intense. Thermo Fisher Scientific, PerkinElmer, Merck, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. The worldwide market for G-Protein Coupled Receptor (GPCR) Targeting is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 91 million US$ in 2023, from 79 million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Thermo Fisher Scientific PerkinElmer Merck BD Biosciences Molecular Devices Promega Qiagen Abcam Corning Cisbio Discoverx Enzo Life Sciences Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers GPCR Consumables GPCR Equipment Market Segment by Applications, can be divided into Oncology Cardiovascular System Central Nervous System Other There are 15 Chapters to deeply display the global G-Protein Coupled Receptor (GPCR) Targeting market. Chapter 1, to describe G-Protein Coupled Receptor (GPCR) Targeting Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of G-Protein Coupled Receptor (GPCR) Targeting, with sales, revenue, and price of G-Protein Coupled Receptor (GPCR) Targeting, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of G-Protein Coupled Receptor (GPCR) Targeting, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, G-Protein Coupled Receptor (GPCR) Targeting market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe G-Protein Coupled Receptor (GPCR) Targeting sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 G-Protein Coupled Receptor (GPCR) Targeting Introduction 1.2 Market Analysis by Type 1.2.1 GPCR Consumables 1.2.2 GPCR Equipment 1.3 Market Analysis by Applications 1.3.1 Oncology 1.3.2 Cardiovascular System 1.3.3 Central Nervous System 1.3.4 Other 1.4 Market Analysis by Regions
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 182036
Category
  • Pharmaceuticals and Healthcare
Published on 18-Jul
Number of Pages 135
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(40)